Open label, Phase I study to assess and compare the pharmacokinetic parameters after multiple oral administration of stiripentol 1000 mg in renal impaired patients and matching controls with normal renal function
STP237
Phase 1 other active
Quick answer
Open label, Phase I study to assess and compare the pharmacokinetic parameters after multiple oral administration of stiripentol 1000 mg in renal impaired patients and matching controls with normal renal function for Patients with renal impairement is a Phase 1 program (other) at Biocodex with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biocodex
- Indication
- Patients with renal impairement
- Phase
- Phase 1
- Modality
- other
- Status
- active